These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Anti-AIDS agents. 52. Synthesis and anti-HIV activity of hydroxymethyl (3'R,4'R)-3',4'-di-O-(S)-camphanoyl-(+)-cis-khellactone derivatives. Xie L; Yu D; Wild C; Allaway G; Turpin J; Smith PC; Lee KH J Med Chem; 2004 Jan; 47(3):756-60. PubMed ID: 14736256 [TBL] [Abstract][Full Text] [Related]
4. Anti-AIDS agents. Part 58: synthesis and anti-HIV activity of 1-thia-di-O-(-)-camphanoyl-(+)-cis-khellactone (1-thia-DCK) analogues. Xia P; Yin ZJ; Chen Y; Zhang Q; Zhang B; Xia Y; Yang ZY; Kilgore N; Wild C; Morris-Natschke SL; Lee KH Bioorg Med Chem Lett; 2004 Jun; 14(12):3341-3. PubMed ID: 15149703 [TBL] [Abstract][Full Text] [Related]
5. Anti-HIV agents. Part 55: 3'R,4'R-Di-(O)-(-)-camphanoyl-2',2'-dimethyldihydropyrano[2,3-f]chromone (DCP), a novel anti-HIV agent. Yu D; Brossi A; Kilgore N; Wild C; Allaway G; Lee KH Bioorg Med Chem Lett; 2003 May; 13(9):1575-6. PubMed ID: 12699758 [TBL] [Abstract][Full Text] [Related]
6. [Progress in the new nonnucleoside anti-HIV reverse transcriptase inhibitor-DCK]. Guo HF; Xie L Yao Xue Xue Bao; 2008 Oct; 43(10):997-1002. PubMed ID: 19127862 [TBL] [Abstract][Full Text] [Related]
7. 6-[1-(4-Fluorophenyl)methyl-1H-pyrrol-2-yl)]-2,4-dioxo-5-hexenoic acid ethyl ester a novel diketo acid derivative which selectively inhibits the HIV-1 viral replication in cell culture and the ribonuclease H activity in vitro. Tramontano E; Esposito F; Badas R; Di Santo R; Costi R; La Colla P Antiviral Res; 2005 Feb; 65(2):117-24. PubMed ID: 15708638 [TBL] [Abstract][Full Text] [Related]
8. Anti-AIDS agents 66: syntheses and anti-HIV activity of phenolic and aza 3',4'-di-O-(-)-camphanoyl-(+)-cis-khellactone (DCK) derivatives. Suzuki M; Yu D; Morris-Natschke SL; Smith PC; Lee KH Bioorg Med Chem; 2007 Nov; 15(21):6852-8. PubMed ID: 17719228 [TBL] [Abstract][Full Text] [Related]
9. The phenylmethylthiazolylthiourea nonnucleoside reverse transcriptase (RT) inhibitor MSK-076 selects for a resistance mutation in the active site of human immunodeficiency virus type 2 RT. Auwerx J; Stevens M; Van Rompay AR; Bird LE; Ren J; De Clercq E; Oberg B; Stammers DK; Karlsson A; Balzarini J J Virol; 2004 Jul; 78(14):7427-37. PubMed ID: 15220416 [TBL] [Abstract][Full Text] [Related]
10. Anti-AIDS agents 87. New bio-isosteric dicamphanoyl-dihydropyranochromone (DCP) and dicamphanoyl-khellactone (DCK) analogues with potent anti-HIV activity. Liu HS; Xu SQ; Cheng M; Chen Y; Xia P; Qian K; Xia Y; Yang ZY; Chen CH; Morris-Natschke SL; Lee KH Bioorg Med Chem Lett; 2011 Oct; 21(19):5831-4. PubMed ID: 21871800 [TBL] [Abstract][Full Text] [Related]
11. Anti-AIDS agents. Part 62: anti-HIV activity of 2'-substituted 4-methyl-3',4'-di-O-(-)-camphanoyl-(+)-cis-khellactone (4-methyl DCK) analogs. Zhang Q; Chen Y; Xia P; Xia Y; Yang ZY; Yu D; Morris-Natschke SL; Lee KH Bioorg Med Chem Lett; 2004 Dec; 14(23):5855-7. PubMed ID: 15501055 [TBL] [Abstract][Full Text] [Related]
12. Anti-AIDS agents. 37. Synthesis and structure-activity relationships of (3'R,4'R)-(+)-cis-khellactone derivatives as novel potent anti-HIV agents. Xie L; Takeuchi Y; Cosentino LM; Lee KH J Med Chem; 1999 Jul; 42(14):2662-72. PubMed ID: 10411486 [TBL] [Abstract][Full Text] [Related]
13. Computational studies and drug design for HIV-1 reverse transcriptase inhibitors of 3',4'-di-O-(S)-camphanoyl-(+)-cis-khellactone (DCK) analogs. Chen HF; Fan BT; Zhao CY; Xie L; Zhao CH; Zhou T; Lee KH; Allaway G J Comput Aided Mol Des; 2005 Apr; 19(4):243-58. PubMed ID: 16163451 [TBL] [Abstract][Full Text] [Related]
14. Antiviral activity and mechanism of action of calanolide A against the human immunodeficiency virus type-1. Currens MJ; Gulakowski RJ; Mariner JM; Moran RA; Buckheit RW; Gustafson KR; McMahon JB; Boyd MR J Pharmacol Exp Ther; 1996 Nov; 279(2):645-51. PubMed ID: 8930167 [TBL] [Abstract][Full Text] [Related]
15. Novel nonnucleoside inhibitors that select nucleoside inhibitor resistance mutations in human immunodeficiency virus type 1 reverse transcriptase. Zhang Z; Walker M; Xu W; Shim JH; Girardet JL; Hamatake RK; Hong Z Antimicrob Agents Chemother; 2006 Aug; 50(8):2772-81. PubMed ID: 16870771 [TBL] [Abstract][Full Text] [Related]
16. Anti-AIDS agents 84. Synthesis and anti-human immunodeficiency virus (HIV) activity of 2'-monomethyl-4-methyl- and 1'-thia-4-methyl-(3'R,4'R)-3',4'-di-O-(S)-camphanoyl-(+)-cis-khellactone (DCK) analogs. Xu SQ; Yan X; Chen Y; Xia P; Qian K; Yu D; Xia Y; Yang ZY; Morris-Natschke SL; Lee KH Bioorg Med Chem; 2010 Oct; 18(20):7203-11. PubMed ID: 20846868 [TBL] [Abstract][Full Text] [Related]
17. Anti-AIDS agents 72. Bioisosteres (7-carbon-DCKs) of the potent anti-HIV lead DCK. Wang Y; Huang SX; Xia P; Xia Y; Yang ZY; Kilgore N; Morris-Natschke SL; Lee KH Bioorg Med Chem Lett; 2007 Aug; 17(15):4316-9. PubMed ID: 17533128 [TBL] [Abstract][Full Text] [Related]
18. Discovery of TSAO derivatives with an unusual HIV-1 activity/resistance profile. de Castro S; García-Aparicio C; Van Laethem K; Gago F; Lobatón E; De Clercq E; Balzarini J; Camarasa MJ; Velázquez S Antiviral Res; 2006 Aug; 71(1):15-23. PubMed ID: 16616962 [TBL] [Abstract][Full Text] [Related]
19. Anti-AIDS agents. 42. Synthesis and anti-HIV activity of disubstituted (3'R,4'R)-3',4'-di-O-(S)-camphanoyl-(+)-cis-khellactone analogues. Xie L; Takeuchi Y; Cosentino LM; McPhail AT; Lee KH J Med Chem; 2001 Mar; 44(5):664-71. PubMed ID: 11262077 [TBL] [Abstract][Full Text] [Related]
20. Non-nucleoside HIV-1 reverse transcriptase inhibitors di-halo-indolyl aryl sulfones achieve tight binding to drug-resistant mutants by targeting the enzyme-substrate complex. Samuele A; Kataropoulou A; Viola M; Zanoli S; La Regina G; Piscitelli F; Silvestri R; Maga G Antiviral Res; 2009 Jan; 81(1):47-55. PubMed ID: 18984007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]